Human Cytomegalovirus Infection Changes the Pattern of Surface Markers of Small Extracellular Vesicles Isolated From First Trimester Placental Long-Term Histocultures.

congenital infection early placenta extracellular vesicles human cytomegalovirus placental histoculture

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2021
Historique:
received: 31 03 2021
accepted: 28 07 2021
entrez: 27 9 2021
pubmed: 28 9 2021
medline: 28 9 2021
Statut: epublish

Résumé

Extracellular vesicles (EVs) have increasingly been recognized as key players in a wide variety of physiological and pathological contexts, including during pregnancy. Notably, EVs appear both as possible biomarkers and as mediators involved in the communication of the placenta with the maternal and fetal sides. A better understanding of the physiological and pathological roles of EVs strongly depends on the development of adequate and reliable study models, specifically at the beginning of pregnancy where many adverse pregnancy outcomes have their origin. In this study, we describe the isolation of small EVs from a histoculture model of first trimester placental explants in normal conditions as well as upon infection by human cytomegalovirus. Using bead-based multiplex cytometry and electron microscopy combined with biochemical approaches, we characterized these small EVs and defined their associated markers and ultrastructure. We observed that infection led to changes in the expression level of several surface markers, without affecting the secretion and integrity of small EVs. Our findings lay the foundation for studying the functional role of EVs during early pregnancy, along with the identification of new predictive biomarkers for the severity and outcome of this congenital infection, which are still sorely lacking.

Identifiants

pubmed: 34568315
doi: 10.3389/fcell.2021.689122
pmc: PMC8461063
doi:

Types de publication

Journal Article

Langues

eng

Pagination

689122

Informations de copyright

Copyright © 2021 Bergamelli, Martin, Bénard, Ausseil, Mansuy, Hurbain, Mouysset, Groussolles, Cartron, Tanguy le Gac, Moinard, Suberbielle, Izopet, Tscherning, Raposo, Gonzalez-Dunia, D’Angelo and Malnou.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS Pathog. 2016 Apr 14;12(4):e1005547
pubmed: 27078877
Am J Reprod Immunol. 2015 Mar;73(3):199-213
pubmed: 25582523
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12048-53
pubmed: 23818581
Biol Reprod. 2009 Oct;81(4):717-29
pubmed: 19494253
Elife. 2020 Sep 10;9:
pubmed: 32910773
Biomark Med. 2019 Jun;13(8):675-684
pubmed: 31157549
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Front Neuroanat. 2013 Jul 19;7:22
pubmed: 23882189
Am J Reprod Immunol. 2018 May;79(5):e12788
pubmed: 29193463
Int J Mol Sci. 2018 Oct 02;19(10):
pubmed: 30279342
Placenta. 2020 Dec;102:34-38
pubmed: 33218576
Stem Cells. 2014 Jun;32(6):1408-19
pubmed: 24578244
PLoS One. 2017 Nov 9;12(11):e0187899
pubmed: 29121670
Diabetes. 2016 Mar;65(3):598-609
pubmed: 26718504
Methods. 2015 Oct 1;87:64-74
pubmed: 25843788
J Extracell Vesicles. 2019 May 23;8(1):1617000
pubmed: 31164969
Placenta. 2017 Jun;54:104-110
pubmed: 28117143
Mol Hum Reprod. 2003 Jun;9(6):359-66
pubmed: 12771237
Placenta. 2017 Nov;59 Suppl 1:S8-S16
pubmed: 28477968
Philos Trans R Soc Lond B Biol Sci. 2015 Mar 5;370(1663):20140066
pubmed: 25602070
Prog Mol Biol Transl Sci. 2017;145:163-179
pubmed: 28110750
Clin Vaccine Immunol. 2015 Feb;22(2):245-7
pubmed: 25520150
Placenta. 2016 Nov;47:86-95
pubmed: 27780544
Placenta. 2018 Apr;64:34-43
pubmed: 29626979
PLoS One. 2012;7(12):e52899
pubmed: 23300810
Early Pregnancy. 1995 Dec;1(4):270-80
pubmed: 9363259
J Virol. 2010 Mar;84(6):2946-54
pubmed: 20042507
PLoS One. 2009 Dec 31;4(12):e8543
pubmed: 20046825
Mol Aspects Med. 2018 Apr;60:69-80
pubmed: 29222068
Ultrasound Obstet Gynecol. 2008 Dec;32(7):900-5
pubmed: 18991327
Virology. 2018 Nov;524:97-105
pubmed: 30165311
J Clin Virol. 2016 Jun;79:25-31
pubmed: 27060652
Nat Protoc. 2009;4(2):256-69
pubmed: 19197269
Nat Methods. 2017 Feb 28;14(3):228-232
pubmed: 28245209
Ann Clin Biochem. 1998 Jul;35 ( Pt 4):460-91
pubmed: 9681050
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Early Pregnancy. 2001 Jan;5(1):67-9
pubmed: 11753519
Placenta. 2019 Jan;75:62-67
pubmed: 30712668
Stem Cell Reports. 2016 Feb 9;6(2):257-72
pubmed: 26862703
Rev Med Virol. 2010 Jul;20(4):202-13
pubmed: 20564615
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Front Pharmacol. 2014 Aug 11;5:175
pubmed: 25157233
Placenta. 2005 Feb-Mar;26(2-3):262-7
pubmed: 15708128
Methods Mol Biol. 2017;1594:43-71
pubmed: 28456976
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S173-81
pubmed: 26428497
Methods Mol Biol. 2018;1710:117-129
pubmed: 29196998
Front Immunol. 2018 Jun 13;9:1326
pubmed: 29951064
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Placenta. 2014 Jun;35(6):345-50
pubmed: 24746852
Placenta. 2019 Jan 15;76:10-18
pubmed: 30803709
J Virol. 2015 May;89(9):5134-47
pubmed: 25741001
J Extracell Vesicles. 2016 Feb 19;5:29975
pubmed: 26901056
Histochem Cell Biol. 2017 May;147(5):565-574
pubmed: 28012129
Placenta. 2011 Jul;32(7):522-30
pubmed: 21605903
J Reprod Immunol. 2014 Oct;104-105:37-42
pubmed: 24915833
Am J Reprod Immunol. 2018 Jul;80(1):e12860
pubmed: 29726582
Am J Obstet Gynecol. 1987 Jun;156(6):1365-74
pubmed: 3035925
Am J Obstet Gynecol. 2008 Apr;198(4):380.e1-7
pubmed: 18191802
J Transl Med. 2014 Aug 08;12:204
pubmed: 25104112
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
Front Genet. 2019 Jan 18;9:706
pubmed: 30713549
Placenta. 2014 Feb;35 Suppl:S93-9
pubmed: 24252708
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Best Pract Res Clin Obstet Gynaecol. 2017 Jan;38:97-107
pubmed: 27923540
Trends Microbiol. 2005 Apr;13(4):164-74
pubmed: 15817386
J Virol. 2019 May 15;93(11):
pubmed: 30894468
Rev Med Virol. 2007 Jul-Aug;17(4):253-76
pubmed: 17579921
Placenta. 2017 Jun;54:83-88
pubmed: 27939894
PLoS One. 2013 Jul 08;8(7):e68451
pubmed: 23861904
Hum Reprod. 2016 Apr;31(4):687-99
pubmed: 26839151

Auteurs

Mathilde Bergamelli (M)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Hélène Martin (H)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Mélinda Bénard (M)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.
Service de Néonatalogie, CHU Toulouse, Hôpital des Enfants, Toulouse, France.

Jérôme Ausseil (J)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.
Laboratoire de Biochimie, CHU Toulouse, Hôpital Rangueil, Toulouse, France.

Jean-Michel Mansuy (JM)

Laboratoire de Virologie, CHU Toulouse, Hôpital Purpan, Toulouse, France.

Ilse Hurbain (I)

CNRS UMR 144, Structure et Compartiments Membranaires, Institut Curie, Université Paris Sciences et Lettres, Paris, France.
CNRS UMR 144, Plateforme d'Imagerie Cellulaire et Tissulaire (PICT-IBiSA), Institut Curie, Université Paris Sciences et Lettres, Paris, France.

Maïlys Mouysset (M)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Marion Groussolles (M)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.
Service de Diagnostic Prénatal, CHU Toulouse, Hôpital Paule de Viguier, Toulouse, France.
INSERM UMR 1027, UPS, Equipe SPHERE Epidémiologie et Analyses en Santé Publique: Risques, Maladies Chroniques et Handicaps, Université de Toulouse, Toulouse, France.

Géraldine Cartron (G)

Service de Gynécologie Obstétrique, CHU Toulouse, Hôpital Paule de Viguier, Toulouse, France.

Yann Tanguy le Gac (Y)

Service de Gynécologie Obstétrique, CHU Toulouse, Hôpital Paule de Viguier, Toulouse, France.

Nathalie Moinard (N)

Développement Embryonnaire, Fertilité, Environnement (DEFE), INSERM UMR 1203, Université de Toulouse et Université de Montpellier, Montpellier, France.
CECOS, Groupe d'Activité de Médecine de la Reproduction, CHU Toulouse, Hôpital Paule de Viguier, Toulouse, France.

Elsa Suberbielle (E)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Jacques Izopet (J)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.
Laboratoire de Virologie, CHU Toulouse, Hôpital Purpan, Toulouse, France.

Charlotte Tscherning (C)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Graça Raposo (G)

CNRS UMR 144, Structure et Compartiments Membranaires, Institut Curie, Université Paris Sciences et Lettres, Paris, France.
CNRS UMR 144, Plateforme d'Imagerie Cellulaire et Tissulaire (PICT-IBiSA), Institut Curie, Université Paris Sciences et Lettres, Paris, France.

Daniel Gonzalez-Dunia (D)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Gisela D'Angelo (G)

CNRS UMR 144, Structure et Compartiments Membranaires, Institut Curie, Université Paris Sciences et Lettres, Paris, France.

Cécile E Malnou (CE)

Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM, CNRS, UPS, Université de Toulouse, Toulouse, France.

Classifications MeSH